| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | EYS CELSR1 FBLN2 FBN2 MEGF8 DLL4 MATN2 EFEMP2 LRP1 LRP2 C1R DSG4 LTBP2 NOTCH2 NOTCH4 | 5.04e-09 | 749 | 61 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 5.85e-06 | 12 | 61 | 3 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 9.64e-06 | 14 | 61 | 3 | GO:0097493 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.48e-05 | 16 | 61 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 3.47e-05 | 21 | 61 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 2.72e-04 | 188 | 61 | 5 | GO:0005201 | |
| GeneOntologyBiologicalProcess | aorta development | 1.45e-07 | 80 | 62 | 6 | GO:0035904 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 3.36e-07 | 92 | 62 | 6 | GO:0048844 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 7.79e-07 | 445 | 62 | 10 | GO:0141091 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.60e-06 | 482 | 62 | 10 | GO:0007178 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | SLC39A12 ERBB4 CELSR1 TRAF6 MEGF8 DLL4 EFEMP2 LRP2 ID4 NOTCH2 NOTCH4 PPP1CA | 1.99e-06 | 750 | 62 | 12 | GO:0048729 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | SLC39A12 ERBB4 CELSR1 TRAF6 MEGF8 DLL4 LRP2 ID4 NOTCH2 NOTCH4 PPP1CA | 2.06e-06 | 619 | 62 | 11 | GO:0002009 |
| GeneOntologyBiologicalProcess | artery development | 2.93e-06 | 133 | 62 | 6 | GO:0060840 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 4.40e-06 | 421 | 62 | 9 | GO:0060562 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 6.89e-06 | 41 | 62 | 4 | GO:0035909 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | BMP6 ERBB4 FBN2 MEGF8 DLL4 ADAM9 LRP1 LRP2 DSG4 LTBP2 NOTCH2 SORL1 | 7.17e-06 | 850 | 62 | 12 | GO:0071363 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | BMP6 ERBB4 FBN2 MEGF8 ADAM9 ZFAND2B LRP1 LRP2 DSG4 LTBP2 EIF2AK3 GFRA3 NOTCH2 SORL1 | 8.65e-06 | 1186 | 62 | 14 | GO:0007167 |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell-matrix adhesion | 8.89e-06 | 2 | 62 | 2 | GO:1905609 | |
| GeneOntologyBiologicalProcess | response to growth factor | BMP6 ERBB4 FBN2 MEGF8 DLL4 ADAM9 LRP1 LRP2 DSG4 LTBP2 NOTCH2 SORL1 | 1.05e-05 | 883 | 62 | 12 | GO:0070848 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 1.58e-05 | 625 | 62 | 10 | GO:0051960 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | PCSK5 BMP6 TRAF6 FBLN2 RASAL3 ADAM9 EFEMP2 LRP1 PHF10 NOTCH4 SPINK5 NOD2 | 1.71e-05 | 927 | 62 | 12 | GO:0030155 |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell differentiation | 2.09e-05 | 54 | 62 | 4 | GO:0051150 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | SLC39A12 CELSR1 TRAF6 MEGF8 DLL4 EFEMP2 LRP1 LRP2 EIF2AK3 NOTCH2 NOTCH4 PPP1CA SPINK5 | 2.41e-05 | 1125 | 62 | 13 | GO:0035239 |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 2.77e-05 | 197 | 62 | 6 | GO:0030509 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | BMP6 TRAF6 FBN2 MEGF8 EFEMP2 BRINP2 LRP1 LRP2 ID4 PHF10 NOTCH2 NOTCH4 PPP1CC | 2.79e-05 | 1141 | 62 | 13 | GO:0045597 |
| GeneOntologyBiologicalProcess | response to BMP | 4.52e-05 | 215 | 62 | 6 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 4.52e-05 | 215 | 62 | 6 | GO:0071773 | |
| GeneOntologyBiologicalProcess | tube development | PCSK5 SLC39A12 CELSR1 TRAF6 MEGF8 DLL4 EFEMP2 LRP1 LRP2 EIF2AK3 NOTCH2 NOTCH4 PPP1CA SPINK5 | 5.58e-05 | 1402 | 62 | 14 | GO:0035295 |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell differentiation | 8.03e-05 | 28 | 62 | 3 | GO:0051152 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 8.84e-05 | 5 | 62 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell-matrix adhesion | 8.84e-05 | 5 | 62 | 2 | GO:2000097 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 8.84e-05 | 5 | 62 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | blood vessel development | PCSK5 SLC39A12 MEGF8 DLL4 EFEMP2 LRP1 LRP2 EIF2AK3 NOTCH2 NOTCH4 SPINK5 | 9.01e-05 | 929 | 62 | 11 | GO:0001568 |
| GeneOntologyBiologicalProcess | epithelium development | BMP6 SLC39A12 ERBB4 CELSR1 TRAF6 MEGF8 DLL4 LRP2 ID4 DSG4 NOTCH2 NOTCH4 PPP1CA SPINK5 | 9.23e-05 | 1469 | 62 | 14 | GO:0060429 |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 9.86e-05 | 80 | 62 | 4 | GO:2000179 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 1.14e-04 | 83 | 62 | 4 | GO:0060976 | |
| GeneOntologyBiologicalProcess | vasculature development | PCSK5 SLC39A12 MEGF8 DLL4 EFEMP2 LRP1 LRP2 EIF2AK3 NOTCH2 NOTCH4 SPINK5 | 1.31e-04 | 969 | 62 | 11 | GO:0001944 |
| GeneOntologyBiologicalProcess | peptide biosynthetic process | 1.45e-04 | 34 | 62 | 3 | GO:0043043 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 1.48e-04 | 515 | 62 | 8 | GO:0050767 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | SLC39A12 MEGF8 DLL4 EFEMP2 LRP1 LRP2 EIF2AK3 NOTCH2 NOTCH4 SPINK5 | 1.49e-04 | 817 | 62 | 10 | GO:0048514 |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 1.85e-04 | 7 | 62 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | smooth muscle cell-matrix adhesion | 1.85e-04 | 7 | 62 | 2 | GO:0061302 | |
| GeneOntologyBiologicalProcess | axon guidance | 2.12e-04 | 285 | 62 | 6 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 2.16e-04 | 286 | 62 | 6 | GO:0097485 | |
| GeneOntologyBiologicalProcess | regulation of cellular localization | BMP6 ERBB4 TRAF6 MALRD1 CACNA2D2 ADAM9 LRP1 LRP2 EIF2AK3 NOTCH4 PPP1CC SORL1 | 2.25e-04 | 1212 | 62 | 12 | GO:0060341 |
| GeneOntologyBiologicalProcess | smooth muscle cell differentiation | 2.25e-04 | 99 | 62 | 4 | GO:0051145 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 2.51e-04 | 418 | 62 | 7 | GO:0051962 | |
| GeneOntologyBiologicalProcess | regulation of antibacterial peptide production | 3.16e-04 | 9 | 62 | 2 | GO:0002786 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | BMP6 CELSR1 TRAF6 RASAL3 ADAM9 DSG4 PHF10 ELFN2 NOTCH4 PPP1CA NOD2 | 3.27e-04 | 1077 | 62 | 11 | GO:0098609 |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 3.27e-04 | 579 | 62 | 8 | GO:0045785 | |
| GeneOntologyBiologicalProcess | regulation of protein localization | BMP6 ERBB4 TRAF6 MALRD1 CACNA2D2 ADAM9 LRP1 LRP2 EIF2AK3 NOTCH4 SORL1 | 3.54e-04 | 1087 | 62 | 11 | GO:0032880 |
| GeneOntologyBiologicalProcess | positive regulation of protein localization | 3.75e-04 | 591 | 62 | 8 | GO:1903829 | |
| GeneOntologyBiologicalProcess | regulation of cell development | TRAF6 MEGF8 DLL4 LRP1 LRP2 ID4 PHF10 NOTCH2 PPP1CC SORL1 SPINK5 | 3.77e-04 | 1095 | 62 | 11 | GO:0060284 |
| GeneOntologyBiologicalProcess | positive regulation of protein transport | 3.88e-04 | 319 | 62 | 6 | GO:0051222 | |
| GeneOntologyBiologicalProcess | positive regulation of lipopolysaccharide-mediated signaling pathway | 3.94e-04 | 10 | 62 | 2 | GO:0031666 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-cell adhesion mediated by cadherin | 3.94e-04 | 10 | 62 | 2 | GO:2000048 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor localization to postsynaptic specialization membrane | 4.32e-04 | 49 | 62 | 3 | GO:0099645 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic specialization membrane | 4.32e-04 | 49 | 62 | 3 | GO:0099633 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 4.40e-04 | 212 | 62 | 5 | GO:0003205 | |
| GeneOntologyBiologicalProcess | regulation of antimicrobial peptide production | 4.80e-04 | 11 | 62 | 2 | GO:0002784 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 4.83e-04 | 614 | 62 | 8 | GO:0010720 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 5.75e-04 | 12 | 62 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | antibacterial peptide production | 5.75e-04 | 12 | 62 | 2 | GO:0002778 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 6.04e-04 | 347 | 62 | 6 | GO:0090092 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process | 6.12e-04 | 228 | 62 | 5 | GO:0045732 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 6.71e-04 | 354 | 62 | 6 | GO:0050769 | |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 6.75e-04 | 233 | 62 | 5 | GO:0061351 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 7.10e-04 | 134 | 62 | 4 | GO:0003279 | |
| GeneOntologyBiologicalProcess | neural tube formation | 7.10e-04 | 134 | 62 | 4 | GO:0001841 | |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 7.30e-04 | 135 | 62 | 4 | GO:2000177 | |
| GeneOntologyBiologicalProcess | cellular response to biotic stimulus | 7.75e-04 | 364 | 62 | 6 | GO:0071216 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 7.90e-04 | 14 | 62 | 2 | GO:1904350 | |
| GeneOntologyBiologicalProcess | regulation of antimicrobial humoral response | 7.90e-04 | 14 | 62 | 2 | GO:0002759 | |
| GeneOntologyBiologicalProcess | antimicrobial peptide production | 7.90e-04 | 14 | 62 | 2 | GO:0002775 | |
| GeneOntologyBiologicalProcess | pattern specification process | 9.86e-04 | 526 | 62 | 7 | GO:0007389 | |
| GeneOntologyBiologicalProcess | anagen | 1.04e-03 | 16 | 62 | 2 | GO:0042640 | |
| GeneOntologyBiologicalProcess | circulatory system development | PCSK5 SLC39A12 ERBB4 MEGF8 DLL4 EFEMP2 LRP1 LRP2 EIF2AK3 NOTCH2 NOTCH4 SPINK5 | 1.07e-03 | 1442 | 62 | 12 | GO:0072359 |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 1.28e-03 | 713 | 62 | 8 | GO:0048598 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | BMP6 ERBB4 CELSR1 TRAF6 FBN2 MEGF8 DLL4 EFEMP2 LRP2 ID4 NOTCH2 | 1.28e-03 | 1269 | 62 | 11 | GO:0009887 |
| GeneOntologyBiologicalProcess | positive regulation of establishment of protein localization | 1.31e-03 | 403 | 62 | 6 | GO:1904951 | |
| GeneOntologyBiologicalProcess | embryonic epithelial tube formation | 1.34e-03 | 159 | 62 | 4 | GO:0001838 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 1.44e-03 | 74 | 62 | 3 | GO:0002011 | |
| GeneOntologyBiologicalProcess | circadian regulation of gene expression | 1.50e-03 | 75 | 62 | 3 | GO:0032922 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane neurotransmitter receptor levels | 1.50e-03 | 164 | 62 | 4 | GO:0099072 | |
| GeneOntologyBiologicalProcess | protein localization to postsynaptic membrane | 1.61e-03 | 77 | 62 | 3 | GO:1903539 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.13e-05 | 656 | 62 | 10 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.19e-05 | 658 | 62 | 10 | GO:0030312 | |
| GeneOntologyCellularComponent | PTW/PP1 phosphatase complex | 1.80e-04 | 7 | 62 | 2 | GO:0072357 | |
| GeneOntologyCellularComponent | microfibril | 6.61e-04 | 13 | 62 | 2 | GO:0001527 | |
| Domain | EGF | PCSK5 EYS CELSR1 FBLN2 FCGBP FBN2 MALRD1 MEGF8 DLL4 ADAM9 MATN2 EFEMP2 BRINP2 LRP1 LRP2 C1R LTBP2 NOTCH2 NOTCH4 SORL1 | 1.72e-23 | 235 | 61 | 20 | SM00181 |
| Domain | EGF-like_dom | PCSK5 EYS CELSR1 FBLN2 FCGBP FBN2 MALRD1 MEGF8 DLL4 ADAM9 MATN2 EFEMP2 LRP1 LRP2 C1R LTBP2 NOTCH2 NOTCH4 SORL1 | 2.13e-21 | 249 | 61 | 19 | IPR000742 |
| Domain | ASX_HYDROXYL | EYS CELSR1 FBLN2 FBN2 MEGF8 DLL4 MATN2 EFEMP2 LRP1 LRP2 C1R LTBP2 NOTCH2 NOTCH4 | 1.13e-19 | 100 | 61 | 14 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | EYS CELSR1 FBLN2 FBN2 MEGF8 DLL4 MATN2 EFEMP2 LRP1 LRP2 C1R LTBP2 NOTCH2 NOTCH4 | 2.67e-19 | 106 | 61 | 14 | IPR000152 |
| Domain | EGF_3 | EYS CELSR1 FBLN2 FBN2 MALRD1 MEGF8 DLL4 ADAM9 MATN2 EFEMP2 LRP1 LRP2 C1R LTBP2 NOTCH2 NOTCH4 SORL1 | 9.11e-19 | 235 | 61 | 17 | PS50026 |
| Domain | Growth_fac_rcpt_ | PCSK5 EYS ERBB4 CELSR1 FBLN2 FBN2 MEGF8 DLL4 MATN2 EFEMP2 LRP1 LRP2 LTBP2 NOTCH2 NOTCH4 | 1.71e-18 | 156 | 61 | 15 | IPR009030 |
| Domain | EGF_CA | EYS CELSR1 FBLN2 FBN2 MEGF8 DLL4 MATN2 EFEMP2 LRP1 LRP2 C1R LTBP2 NOTCH2 NOTCH4 | 2.08e-18 | 122 | 61 | 14 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | EYS CELSR1 FBLN2 FBN2 MEGF8 DLL4 MATN2 EFEMP2 LRP1 LRP2 C1R LTBP2 NOTCH2 NOTCH4 | 2.63e-18 | 124 | 61 | 14 | IPR001881 |
| Domain | EGF-like_CS | EYS CELSR1 FBLN2 FBN2 MALRD1 MEGF8 DLL4 ADAM9 MATN2 EFEMP2 LRP1 LRP2 C1R LTBP2 NOTCH2 NOTCH4 SORL1 | 5.43e-18 | 261 | 61 | 17 | IPR013032 |
| Domain | EGF_2 | EYS CELSR1 FBLN2 FBN2 MALRD1 MEGF8 DLL4 ADAM9 MATN2 EFEMP2 LRP1 LRP2 C1R LTBP2 NOTCH2 NOTCH4 SORL1 | 7.03e-18 | 265 | 61 | 17 | PS01186 |
| Domain | EGF_1 | EYS CELSR1 FBLN2 FBN2 MALRD1 MEGF8 DLL4 ADAM9 EFEMP2 LRP1 LRP2 C1R LTBP2 NOTCH2 NOTCH4 | 2.85e-15 | 255 | 61 | 15 | PS00022 |
| Domain | EGF_CA | FBLN2 FBN2 MEGF8 MATN2 EFEMP2 LRP1 LRP2 C1R LTBP2 NOTCH2 NOTCH4 | 3.53e-15 | 86 | 61 | 11 | PF07645 |
| Domain | EGF_Ca-bd_CS | EYS FBLN2 FBN2 MEGF8 EFEMP2 LRP1 LRP2 C1R LTBP2 NOTCH2 NOTCH4 | 1.40e-14 | 97 | 61 | 11 | IPR018097 |
| Domain | EGF_CA | EYS FBLN2 FBN2 MEGF8 EFEMP2 LRP1 LRP2 C1R LTBP2 NOTCH2 NOTCH4 | 1.76e-14 | 99 | 61 | 11 | PS01187 |
| Domain | EGF | 9.17e-12 | 126 | 61 | 10 | PF00008 | |
| Domain | cEGF | 2.06e-10 | 26 | 61 | 6 | IPR026823 | |
| Domain | cEGF | 2.06e-10 | 26 | 61 | 6 | PF12662 | |
| Domain | hEGF | 1.99e-06 | 28 | 61 | 4 | PF12661 | |
| Domain | LDLR_class-A_CS | 8.62e-06 | 40 | 61 | 4 | IPR023415 | |
| Domain | TIL_dom | 1.18e-05 | 14 | 61 | 3 | IPR002919 | |
| Domain | Ldl_recept_b | 1.18e-05 | 14 | 61 | 3 | PF00058 | |
| Domain | LDLRB | 1.18e-05 | 14 | 61 | 3 | PS51120 | |
| Domain | Ldl_recept_a | 1.39e-05 | 45 | 61 | 4 | PF00057 | |
| Domain | LY | 1.47e-05 | 15 | 61 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.47e-05 | 15 | 61 | 3 | IPR000033 | |
| Domain | - | 1.52e-05 | 46 | 61 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 1.80e-05 | 48 | 61 | 4 | PS01209 | |
| Domain | LDLRA_2 | 1.95e-05 | 49 | 61 | 4 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.95e-05 | 49 | 61 | 4 | IPR002172 | |
| Domain | LDLa | 1.95e-05 | 49 | 61 | 4 | SM00192 | |
| Domain | STPPase_N | 3.14e-05 | 3 | 61 | 2 | IPR031675 | |
| Domain | STPPase_N | 3.14e-05 | 3 | 61 | 2 | PF16891 | |
| Domain | EGF_extracell | 4.38e-05 | 60 | 61 | 4 | IPR013111 | |
| Domain | EGF_2 | 4.38e-05 | 60 | 61 | 4 | PF07974 | |
| Domain | Notch | 6.27e-05 | 4 | 61 | 2 | IPR008297 | |
| Domain | NODP | 6.27e-05 | 4 | 61 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 6.27e-05 | 4 | 61 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 6.27e-05 | 4 | 61 | 2 | IPR010660 | |
| Domain | NOD | 6.27e-05 | 4 | 61 | 2 | PF06816 | |
| Domain | NOD | 6.27e-05 | 4 | 61 | 2 | SM01338 | |
| Domain | NODP | 6.27e-05 | 4 | 61 | 2 | SM01339 | |
| Domain | LNR | 1.04e-04 | 5 | 61 | 2 | PS50258 | |
| Domain | GF_recep_IV | 1.56e-04 | 6 | 61 | 2 | PF14843 | |
| Domain | GF_recep_IV | 1.56e-04 | 6 | 61 | 2 | IPR032778 | |
| Domain | TB | 2.18e-04 | 7 | 61 | 2 | PF00683 | |
| Domain | Notch_dom | 2.18e-04 | 7 | 61 | 2 | IPR000800 | |
| Domain | Notch | 2.18e-04 | 7 | 61 | 2 | PF00066 | |
| Domain | NL | 2.18e-04 | 7 | 61 | 2 | SM00004 | |
| Domain | - | 2.79e-04 | 39 | 61 | 3 | 2.120.10.30 | |
| Domain | - | 2.90e-04 | 8 | 61 | 2 | 3.90.290.10 | |
| Domain | TB | 3.72e-04 | 9 | 61 | 2 | PS51364 | |
| Domain | TB_dom | 3.72e-04 | 9 | 61 | 2 | IPR017878 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.55e-04 | 46 | 61 | 3 | IPR011042 | |
| Domain | TIL | 6.78e-04 | 12 | 61 | 2 | PF01826 | |
| Domain | C8 | 6.78e-04 | 12 | 61 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 8.00e-04 | 13 | 61 | 2 | IPR014853 | |
| Domain | Ser/Thr-sp_prot-phosphatase | 8.00e-04 | 13 | 61 | 2 | IPR006186 | |
| Domain | C8 | 8.00e-04 | 13 | 61 | 2 | SM00832 | |
| Domain | SER_THR_PHOSPHATASE | 8.00e-04 | 13 | 61 | 2 | PS00125 | |
| Domain | PP2Ac | 8.00e-04 | 13 | 61 | 2 | SM00156 | |
| Domain | VWD | 1.22e-03 | 16 | 61 | 2 | SM00216 | |
| Domain | VWF_type-D | 1.22e-03 | 16 | 61 | 2 | IPR001846 | |
| Domain | VWFD | 1.22e-03 | 16 | 61 | 2 | PS51233 | |
| Domain | VWD | 1.22e-03 | 16 | 61 | 2 | PF00094 | |
| Domain | Furin_repeat | 1.55e-03 | 18 | 61 | 2 | IPR006212 | |
| Domain | FU | 1.55e-03 | 18 | 61 | 2 | SM00261 | |
| Domain | VWC_out | 1.73e-03 | 19 | 61 | 2 | SM00215 | |
| Domain | Calcineurin-like_PHP_ApaH | 3.76e-03 | 28 | 61 | 2 | IPR004843 | |
| Domain | Metallophos | 3.76e-03 | 28 | 61 | 2 | PF00149 | |
| Domain | Metallo-depent_PP-like | 4.30e-03 | 30 | 61 | 2 | IPR029052 | |
| Domain | - | 4.30e-03 | 30 | 61 | 2 | 3.60.21.10 | |
| Domain | EGF_LAM_2 | 4.30e-03 | 30 | 61 | 2 | PS50027 | |
| Domain | EGF_LAM_1 | 4.30e-03 | 30 | 61 | 2 | PS01248 | |
| Domain | Laminin_EGF | 5.83e-03 | 35 | 61 | 2 | PF00053 | |
| Domain | EGF_Lam | 5.83e-03 | 35 | 61 | 2 | SM00180 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.30e-06 | 32 | 42 | 4 | MM14854 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 4.19e-06 | 37 | 42 | 4 | M27134 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 5.19e-06 | 39 | 42 | 4 | MM14601 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 6.89e-06 | 13 | 42 | 3 | M47423 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 8.47e-06 | 44 | 42 | 4 | M26969 | |
| Pathway | REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS | 1.11e-05 | 47 | 42 | 4 | M646 | |
| Pathway | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | 3.64e-05 | 22 | 42 | 3 | M859 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 3.64e-05 | 22 | 42 | 3 | M27210 | |
| Pathway | REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1 | 4.18e-05 | 23 | 42 | 3 | MM15134 | |
| Pathway | REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION | 4.18e-05 | 23 | 42 | 3 | M17243 | |
| Pathway | REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION | 4.77e-05 | 24 | 42 | 3 | MM15133 | |
| Pathway | REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING | 6.10e-05 | 26 | 42 | 3 | M628 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 6.84e-05 | 27 | 42 | 3 | M39545 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 8.62e-05 | 5 | 42 | 2 | M27411 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 1.01e-04 | 82 | 42 | 4 | M594 | |
| Pathway | REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES | 1.15e-04 | 32 | 42 | 3 | MM15290 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 1.26e-04 | 33 | 42 | 3 | M604 | |
| Pathway | REACTOME_NOD1_2_SIGNALING_PATHWAY | 1.26e-04 | 33 | 42 | 3 | MM14663 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3 | 1.27e-04 | 87 | 42 | 4 | M39465 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 1.29e-04 | 6 | 42 | 2 | M27068 | |
| Pathway | REACTOME_NOD1_2_SIGNALING_PATHWAY | 1.64e-04 | 36 | 42 | 3 | M1059 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 1.71e-04 | 94 | 42 | 4 | M1041 | |
| Pathway | REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES | 2.09e-04 | 39 | 42 | 3 | M27579 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.09e-04 | 39 | 42 | 3 | MM14604 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE | 2.40e-04 | 8 | 42 | 2 | M47933 | |
| Pathway | REACTOME_TAK1_DEPENDENT_IKK_AND_NF_KAPPA_B_ACTIVATION | 2.99e-04 | 44 | 42 | 3 | M852 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING | 3.08e-04 | 9 | 42 | 2 | M26930 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING | 3.08e-04 | 9 | 42 | 2 | MM14535 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 3.20e-04 | 45 | 42 | 3 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 3.41e-04 | 46 | 42 | 3 | MM15971 | |
| Pathway | WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION | 3.41e-04 | 46 | 42 | 3 | M39901 | |
| Pathway | REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS | 3.64e-04 | 47 | 42 | 3 | MM14664 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 3.64e-04 | 47 | 42 | 3 | M7946 | |
| Pathway | REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX | 3.84e-04 | 10 | 42 | 2 | MM15647 | |
| Pathway | REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX | 3.84e-04 | 10 | 42 | 2 | M27925 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 4.69e-04 | 11 | 42 | 2 | M47865 | |
| Pathway | REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY | 4.69e-04 | 11 | 42 | 2 | M29827 | |
| Pathway | REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX | 4.69e-04 | 11 | 42 | 2 | M27885 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 4.69e-04 | 11 | 42 | 2 | M27882 | |
| Pathway | REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY | 4.69e-04 | 11 | 42 | 2 | MM15668 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CENPE_INTERACTION_WITH_NDC80_COMPLEX | 5.61e-04 | 12 | 42 | 2 | M47887 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEPHOSPHORYLATION_OF_KINETOCHORE | 5.61e-04 | 12 | 42 | 2 | M47891 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 5.61e-04 | 12 | 42 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 5.61e-04 | 12 | 42 | 2 | M47533 | |
| Pathway | REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS | 6.11e-04 | 56 | 42 | 3 | M1074 | |
| Pathway | REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES | 6.62e-04 | 13 | 42 | 2 | MM14827 | |
| Pathway | REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL | 6.62e-04 | 13 | 42 | 2 | MM14828 | |
| Pathway | REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES | 6.62e-04 | 13 | 42 | 2 | M14582 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 6.62e-04 | 13 | 42 | 2 | M47534 | |
| Pathway | REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING | 6.62e-04 | 13 | 42 | 2 | M967 | |
| Pathway | REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL | 6.62e-04 | 13 | 42 | 2 | M736 | |
| Pathway | REACTOME_INTERLEUKIN_17_SIGNALING | 7.12e-04 | 59 | 42 | 3 | MM15128 | |
| Pathway | PID_NOTCH_PATHWAY | 7.12e-04 | 59 | 42 | 3 | M17 | |
| Pathway | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | 7.71e-04 | 14 | 42 | 2 | MM14826 | |
| Pathway | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | 7.71e-04 | 14 | 42 | 2 | M935 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 7.85e-04 | 61 | 42 | 3 | M39540 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 8.88e-04 | 15 | 42 | 2 | M27202 | |
| Pathway | REACTOME_IRAK1_RECRUITS_IKK_COMPLEX | 8.88e-04 | 15 | 42 | 2 | MM15645 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_GENOME_REPLICATION_TRANSCRIPTION_AND_TRANSLATION | 1.01e-03 | 16 | 42 | 2 | M48235 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 1.01e-03 | 16 | 42 | 2 | M47424 | |
| Pathway | REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS | 1.01e-03 | 16 | 42 | 2 | M7257 | |
| Pathway | REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX | 1.01e-03 | 16 | 42 | 2 | M1000 | |
| Pathway | REACTOME_P75NTR_SIGNALS_VIA_NF_KB | 1.01e-03 | 16 | 42 | 2 | M18175 | |
| Pathway | REACTOME_P75NTR_SIGNALS_VIA_NF_KB | 1.01e-03 | 16 | 42 | 2 | MM14742 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.08e-03 | 68 | 42 | 3 | M27303 | |
| Pathway | REACTOME_REGULATION_OF_NF_KAPPA_B_SIGNALING | 1.15e-03 | 17 | 42 | 2 | MM15702 | |
| Pathway | REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX | 1.15e-03 | 17 | 42 | 2 | MM15648 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 1.17e-03 | 70 | 42 | 3 | M938 | |
| Pathway | REACTOME_INTERLEUKIN_17_SIGNALING | 1.22e-03 | 71 | 42 | 3 | M27382 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION | 1.29e-03 | 18 | 42 | 2 | MM15342 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 1.29e-03 | 18 | 42 | 2 | M614 | |
| Pathway | REACTOME_REGULATION_OF_NF_KAPPA_B_SIGNALING | 1.29e-03 | 18 | 42 | 2 | M45023 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.31e-03 | 161 | 42 | 4 | M39770 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 1.31e-03 | 161 | 42 | 4 | M27871 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.43e-03 | 19 | 42 | 2 | MM15594 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION | 1.43e-03 | 19 | 42 | 2 | M27639 | |
| Pathway | REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT | 1.43e-03 | 19 | 42 | 2 | M27020 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.59e-03 | 20 | 42 | 2 | M27881 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.85e-03 | 82 | 42 | 3 | MM15922 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.88e-03 | 300 | 42 | 5 | M610 | |
| Pathway | REACTOME_MYD88_MAL_TIRAP_CASCADE_INITIATED_ON_PLASMA_MEMBRANE | 2.05e-03 | 85 | 42 | 3 | MM14645 | |
| Pathway | REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1 | 2.11e-03 | 23 | 42 | 2 | M1003 | |
| Pathway | PID_NFKAPPAB_CANONICAL_PATHWAY | 2.11e-03 | 23 | 42 | 2 | M37 | |
| Pathway | REACTOME_TRIGLYCERIDE_CATABOLISM | 2.29e-03 | 24 | 42 | 2 | M10064 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 2.29e-03 | 24 | 42 | 2 | M11190 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 2.43e-03 | 318 | 42 | 5 | MM15278 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 2.49e-03 | 25 | 42 | 2 | M39713 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 2.49e-03 | 25 | 42 | 2 | M27879 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 2.49e-03 | 25 | 42 | 2 | M47948 | |
| Pathway | REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1 | 2.49e-03 | 25 | 42 | 2 | MM15646 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 2.69e-03 | 26 | 42 | 2 | MM15501 | |
| Pathway | REACTOME_MAPK_FAMILY_SIGNALING_CASCADES | 2.74e-03 | 327 | 42 | 5 | M27565 | |
| Pathway | WP_CIRCADIAN_RHYTHM_GENES | 2.94e-03 | 201 | 42 | 4 | M39605 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 2.99e-03 | 97 | 42 | 3 | MM15926 | |
| Pathway | REACTOME_SARS_COV_1_HOST_INTERACTIONS | 3.07e-03 | 98 | 42 | 3 | M46424 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 3.10e-03 | 204 | 42 | 4 | M45011 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 3.12e-03 | 28 | 42 | 2 | M6177 | |
| Pathway | REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE | 3.16e-03 | 99 | 42 | 3 | MM14660 | |
| Pathway | REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING | 3.34e-03 | 29 | 42 | 2 | M27756 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 3.35e-03 | 101 | 42 | 3 | M39448 | |
| Pubmed | 2.16e-08 | 4 | 62 | 3 | 38462037 | ||
| Pubmed | Expression patterns of Notch receptors and their ligands Jagged and Delta in human placenta. | 5.38e-08 | 5 | 62 | 3 | 21726900 | |
| Pubmed | 5.38e-08 | 5 | 62 | 3 | 23675950 | ||
| Pubmed | 5.38e-08 | 5 | 62 | 3 | 19047013 | ||
| Pubmed | 7.06e-08 | 118 | 62 | 6 | 21078624 | ||
| Pubmed | 1.07e-07 | 6 | 62 | 3 | 29228365 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 3.03e-07 | 248 | 62 | 7 | 24006456 | |
| Pubmed | 4.50e-07 | 9 | 62 | 3 | 16245338 | ||
| Pubmed | Notch signaling regulates smooth muscle differentiation of epicardium-derived cells. | 4.60e-07 | 35 | 62 | 4 | 21252157 | |
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 6.42e-07 | 10 | 62 | 3 | 23665443 | |
| Pubmed | 8.82e-07 | 41 | 62 | 4 | 22675208 | ||
| Pubmed | 1.17e-06 | 12 | 62 | 3 | 15465494 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | BMP6 CELSR1 FBN2 MEGF8 ADAM9 MATN2 RPS12 LRP1 LTBP2 EIF2AK3 NOTCH2 SORL1 | 1.19e-06 | 1201 | 62 | 12 | 35696571 |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 1.52e-06 | 13 | 62 | 3 | 11578869 | |
| Pubmed | Endothelial Jarid2/Jumonji is required for normal cardiac development and proper Notch1 expression. | 1.94e-06 | 14 | 62 | 3 | 21402699 | |
| Pubmed | 1.94e-06 | 14 | 62 | 3 | 14757642 | ||
| Pubmed | 2.42e-06 | 15 | 62 | 3 | 12971992 | ||
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 2.97e-06 | 16 | 62 | 3 | 12617809 | |
| Pubmed | 2.97e-06 | 16 | 62 | 3 | 36484700 | ||
| Pubmed | 2.97e-06 | 16 | 62 | 3 | 17273555 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 21045140 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 34445520 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 11532344 | ||
| Pubmed | PP-1α and PP-1γ display antagonism and differential roles in tumorigenicity of lung cancer cells. | 3.13e-06 | 2 | 62 | 2 | 23176181 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 37071303 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 31964525 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 23587900 | ||
| Pubmed | ErbB4 is an upstream regulator of TTF-1 fetal mouse lung type II cell development in vitro. | 3.13e-06 | 2 | 62 | 2 | 23845988 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 9882500 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 12814948 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 20643108 | ||
| Pubmed | 3.60e-06 | 17 | 62 | 3 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 3.60e-06 | 17 | 62 | 3 | 15821257 | |
| Pubmed | 3.60e-06 | 17 | 62 | 3 | 39315665 | ||
| Pubmed | 4.32e-06 | 18 | 62 | 3 | 18093989 | ||
| Pubmed | 4.32e-06 | 18 | 62 | 3 | 15689374 | ||
| Pubmed | 5.12e-06 | 19 | 62 | 3 | 16518823 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | 5.29e-06 | 724 | 62 | 9 | 36232890 | |
| Pubmed | 7.01e-06 | 21 | 62 | 3 | 28656980 | ||
| Pubmed | 7.38e-06 | 963 | 62 | 10 | 28671696 | ||
| Pubmed | 8.13e-06 | 71 | 62 | 4 | 33541421 | ||
| Pubmed | 9.31e-06 | 23 | 62 | 3 | 14701881 | ||
| Pubmed | 9.31e-06 | 23 | 62 | 3 | 36239412 | ||
| Pubmed | Helicobacter pylori Infection of Gastric Epithelial Cells Affects NOTCH Pathway In Vitro. | 9.37e-06 | 3 | 62 | 2 | 27073072 | |
| Pubmed | Id4 Downstream of Notch2 Maintains Neural Stem Cell Quiescence in the Adult Hippocampus. | 9.37e-06 | 3 | 62 | 2 | 31390563 | |
| Pubmed | Mutually exclusive binding of PP1 and RNA to AKAP149 affects the mitochondrial network. | 9.37e-06 | 3 | 62 | 2 | 19074462 | |
| Pubmed | Differential expression of Notch genes in human osteoblastic cells. | 9.37e-06 | 3 | 62 | 2 | 11836628 | |
| Pubmed | 1E7-03, a low MW compound targeting host protein phosphatase-1, inhibits HIV-1 transcription. | 9.37e-06 | 3 | 62 | 2 | 25073485 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 21700711 | ||
| Pubmed | Protein phosphatase 1 (PP1) is a post-translational regulator of the mammalian circadian clock. | 9.37e-06 | 3 | 62 | 2 | 21712997 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 17965019 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 33351914 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 30793522 | ||
| Pubmed | KLF13 restrains Dll4-muscular Notch2 axis to improve the muscle atrophy. | 9.37e-06 | 3 | 62 | 2 | 38973459 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 12138106 | ||
| Pubmed | Delta-like 4/Notch pathway is differentially regulated in benign and malignant thyroid tissues. | 9.37e-06 | 3 | 62 | 2 | 22066479 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 7857673 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 11823422 | ||
| Pubmed | Dynamic targeting of protein phosphatase 1 within the nuclei of living mammalian cells. | 9.37e-06 | 3 | 62 | 2 | 11739654 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 11588169 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 28799085 | ||
| Pubmed | Notch signaling: cell fate control and signal integration in development. | 9.37e-06 | 3 | 62 | 2 | 10221902 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 16951162 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 28572448 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 9882488 | ||
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 26472724 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | 9.89e-06 | 420 | 62 | 7 | 28065597 | |
| Pubmed | 1.06e-05 | 24 | 62 | 3 | 21633169 | ||
| Pubmed | Notch signaling controls liver development by regulating biliary differentiation. | 1.36e-05 | 26 | 62 | 3 | 19369401 | |
| Pubmed | Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex. | 1.44e-05 | 82 | 62 | 4 | 31073041 | |
| Pubmed | Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. | 1.53e-05 | 27 | 62 | 3 | 21791528 | |
| Pubmed | 1.74e-05 | 86 | 62 | 4 | 35103284 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.74e-05 | 86 | 62 | 4 | 28327460 | |
| Pubmed | Coordinated regulation of Toll-like receptor and NOD2 signaling by K63-linked polyubiquitin chains. | 1.87e-05 | 4 | 62 | 2 | 17562858 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 23499489 | ||
| Pubmed | Prognostic roles of mRNA expression of notch receptors in non-small cell lung cancer. | 1.87e-05 | 4 | 62 | 2 | 28061457 | |
| Pubmed | Nuclear targeting of protein phosphatase-1 by HIV-1 Tat protein. | 1.87e-05 | 4 | 62 | 2 | 16131488 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 24145721 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 10194355 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 20069356 | ||
| Pubmed | Expression and clinical significance of Notch receptors in human renal cell carcinoma. | 1.87e-05 | 4 | 62 | 2 | 19404845 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 28669409 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 12413896 | ||
| Pubmed | Canonical Notch ligands and Fringes have distinct effects on NOTCH1 and NOTCH2. | 1.87e-05 | 4 | 62 | 2 | 32820046 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 11466531 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 10880350 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 24151014 | ||
| Pubmed | Forelimb contractures and abnormal tendon collagen fibrillogenesis in fibulin-4 null mice. | 1.87e-05 | 4 | 62 | 2 | 26711913 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 15226296 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 22768081 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 11401408 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 10807923 | ||
| Pubmed | Notch as a mediator of cell fate determination in hematopoiesis: evidence and speculation. | 1.87e-05 | 4 | 62 | 2 | 10194420 | |
| Pubmed | Fibroblastic niches prime T cell alloimmunity through Delta-like Notch ligands. | 1.87e-05 | 4 | 62 | 2 | 28319044 | |
| Pubmed | Functional conservation of mouse Notch receptor family members. | 1.87e-05 | 4 | 62 | 2 | 8898100 | |
| Pubmed | Nuclear protein phosphatase-1 regulates HIV-1 transcription. | 1.87e-05 | 4 | 62 | 2 | 12788939 | |
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 36376768 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 11459941 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 7775583 | ||
| Pubmed | 1.87e-05 | 4 | 62 | 2 | 11421580 | ||
| Interaction | ZNF408 interactions | 9.62e-09 | 145 | 59 | 8 | int:ZNF408 | |
| Interaction | ZFP41 interactions | 1.57e-08 | 57 | 59 | 6 | int:ZFP41 | |
| Interaction | IGFL3 interactions | 8.35e-08 | 75 | 59 | 6 | int:IGFL3 | |
| Interaction | ZNF628 interactions | 1.17e-07 | 16 | 59 | 4 | int:ZNF628 | |
| Interaction | ZNF865 interactions | 2.53e-07 | 47 | 59 | 5 | int:ZNF865 | |
| Interaction | NTN5 interactions | 6.74e-07 | 24 | 59 | 4 | int:NTN5 | |
| Interaction | LYPD1 interactions | 7.36e-07 | 58 | 59 | 5 | int:LYPD1 | |
| Interaction | ZNF594 interactions | 8.27e-07 | 7 | 59 | 3 | int:ZNF594 | |
| Interaction | CACNA1A interactions | 1.58e-06 | 123 | 59 | 6 | int:CACNA1A | |
| Interaction | CFC1 interactions | 1.82e-06 | 126 | 59 | 6 | int:CFC1 | |
| Interaction | DUSP10 interactions | 2.03e-06 | 71 | 59 | 5 | int:DUSP10 | |
| Interaction | GREM2 interactions | 4.07e-06 | 37 | 59 | 4 | int:GREM2 | |
| Interaction | SIRPD interactions | 5.25e-06 | 86 | 59 | 5 | int:SIRPD | |
| Interaction | ZNF709 interactions | 6.68e-06 | 13 | 59 | 3 | int:ZNF709 | |
| Interaction | MDK interactions | 6.94e-06 | 91 | 59 | 5 | int:MDK | |
| Interaction | CTSG interactions | 8.57e-06 | 95 | 59 | 5 | int:CTSG | |
| Interaction | ZNF316 interactions | 9.86e-06 | 46 | 59 | 4 | int:ZNF316 | |
| Interaction | CD160 interactions | 1.17e-05 | 48 | 59 | 4 | int:CD160 | |
| Interaction | PRR16 interactions | 1.30e-05 | 16 | 59 | 3 | int:PRR16 | |
| Interaction | PRG2 interactions | 1.91e-05 | 285 | 59 | 7 | int:PRG2 | |
| Interaction | PPP1R3B interactions | 2.23e-05 | 19 | 59 | 3 | int:PPP1R3B | |
| Interaction | ZNF358 interactions | 2.23e-05 | 19 | 59 | 3 | int:ZNF358 | |
| Interaction | FBXO2 interactions | 2.50e-05 | 411 | 59 | 8 | int:FBXO2 | |
| Interaction | ZNF224 interactions | 2.62e-05 | 20 | 59 | 3 | int:ZNF224 | |
| Interaction | ZNF627 interactions | 2.62e-05 | 20 | 59 | 3 | int:ZNF627 | |
| Interaction | NOTCH4 interactions | 3.05e-05 | 21 | 59 | 3 | int:NOTCH4 | |
| Interaction | ST14 interactions | 3.13e-05 | 207 | 59 | 6 | int:ST14 | |
| Interaction | FBN2 interactions | 3.93e-05 | 65 | 59 | 4 | int:FBN2 | |
| Interaction | PPP1R2C interactions | 5.04e-05 | 4 | 59 | 2 | int:PPP1R2C | |
| Interaction | ZNF775 interactions | 5.24e-05 | 25 | 59 | 3 | int:ZNF775 | |
| Interaction | FIBIN interactions | 5.56e-05 | 71 | 59 | 4 | int:FIBIN | |
| Interaction | SLURP1 interactions | 6.38e-05 | 144 | 59 | 5 | int:SLURP1 | |
| Interaction | ZNF263 interactions | 7.50e-05 | 149 | 59 | 5 | int:ZNF263 | |
| Interaction | TAFA3 interactions | 8.04e-05 | 78 | 59 | 4 | int:TAFA3 | |
| Interaction | CSRNP2 interactions | 8.38e-05 | 5 | 59 | 2 | int:CSRNP2 | |
| Interaction | ZNF837 interactions | 8.45e-05 | 79 | 59 | 4 | int:ZNF837 | |
| Interaction | BTNL2 interactions | 9.04e-05 | 155 | 59 | 5 | int:BTNL2 | |
| Interaction | FURIN interactions | 9.95e-05 | 255 | 59 | 6 | int:FURIN | |
| Interaction | ZNF664 interactions | 1.01e-04 | 31 | 59 | 3 | int:ZNF664 | |
| Interaction | DLL4 interactions | 1.25e-04 | 6 | 59 | 2 | int:DLL4 | |
| Interaction | SFRP5 interactions | 1.25e-04 | 6 | 59 | 2 | int:SFRP5 | |
| Interaction | ANKS1B interactions | 1.34e-04 | 34 | 59 | 3 | int:ANKS1B | |
| Interaction | PPP1R14B interactions | 1.34e-04 | 34 | 59 | 3 | int:PPP1R14B | |
| Interaction | ZNF324B interactions | 1.34e-04 | 89 | 59 | 4 | int:ZNF324B | |
| Interaction | NDP interactions | 1.46e-04 | 35 | 59 | 3 | int:NDP | |
| Interaction | CCND3 interactions | 1.46e-04 | 91 | 59 | 4 | int:CCND3 | |
| Interaction | GAGE2E interactions | 1.59e-04 | 36 | 59 | 3 | int:GAGE2E | |
| Interaction | DLK2 interactions | 1.59e-04 | 36 | 59 | 3 | int:DLK2 | |
| Interaction | NTRK2 interactions | 1.64e-04 | 176 | 59 | 5 | int:NTRK2 | |
| Interaction | SLC45A1 interactions | 1.75e-04 | 7 | 59 | 2 | int:SLC45A1 | |
| Interaction | RPL10 interactions | 1.90e-04 | 702 | 59 | 9 | int:RPL10 | |
| Interaction | CELF1 interactions | 1.93e-04 | 288 | 59 | 6 | int:CELF1 | |
| Interaction | NUFIP2 interactions | 2.08e-04 | 417 | 59 | 7 | int:NUFIP2 | |
| Interaction | ATN1 interactions | 2.18e-04 | 187 | 59 | 5 | int:ATN1 | |
| Interaction | CCN2 interactions | 2.18e-04 | 40 | 59 | 3 | int:CCN2 | |
| Interaction | PPP1R15A interactions | 2.18e-04 | 40 | 59 | 3 | int:PPP1R15A | |
| Interaction | E4F1 interactions | 2.19e-04 | 101 | 59 | 4 | int:E4F1 | |
| Interaction | NOTCH2 interactions | 2.27e-04 | 423 | 59 | 7 | int:NOTCH2 | |
| Interaction | SLC16A5 interactions | 2.33e-04 | 8 | 59 | 2 | int:SLC16A5 | |
| Interaction | BMPER interactions | 2.33e-04 | 8 | 59 | 2 | int:BMPER | |
| Interaction | RASSF7 interactions | 2.52e-04 | 42 | 59 | 3 | int:RASSF7 | |
| Interaction | ZNF398 interactions | 2.71e-04 | 43 | 59 | 3 | int:ZNF398 | |
| Interaction | EDN3 interactions | 2.83e-04 | 108 | 59 | 4 | int:EDN3 | |
| Interaction | ZNF480 interactions | 2.99e-04 | 9 | 59 | 2 | int:ZNF480 | |
| Interaction | ZKSCAN2 interactions | 2.99e-04 | 9 | 59 | 2 | int:ZKSCAN2 | |
| Interaction | SOCS3 interactions | 3.04e-04 | 110 | 59 | 4 | int:SOCS3 | |
| Interaction | RBM47 interactions | 3.25e-04 | 204 | 59 | 5 | int:RBM47 | |
| Interaction | ZNF324 interactions | 3.31e-04 | 46 | 59 | 3 | int:ZNF324 | |
| Interaction | SDF2L1 interactions | 3.51e-04 | 322 | 59 | 6 | int:SDF2L1 | |
| Interaction | TRAF4 interactions | 3.55e-04 | 208 | 59 | 5 | int:TRAF4 | |
| Interaction | ZNF766 interactions | 3.73e-04 | 10 | 59 | 2 | int:ZNF766 | |
| Interaction | MMP17 interactions | 3.73e-04 | 10 | 59 | 2 | int:MMP17 | |
| Interaction | LYZL1 interactions | 3.96e-04 | 118 | 59 | 4 | int:LYZL1 | |
| Interaction | PRG3 interactions | 3.99e-04 | 49 | 59 | 3 | int:PRG3 | |
| Interaction | PATE1 interactions | 3.99e-04 | 49 | 59 | 3 | int:PATE1 | |
| Interaction | DKK2 interactions | 3.99e-04 | 49 | 59 | 3 | int:DKK2 | |
| Interaction | FOXD4L6 interactions | 3.99e-04 | 49 | 59 | 3 | int:FOXD4L6 | |
| Interaction | ALKAL2 interactions | 4.56e-04 | 11 | 59 | 2 | int:ALKAL2 | |
| Interaction | NPNT interactions | 4.56e-04 | 11 | 59 | 2 | int:NPNT | |
| Interaction | HLA-DRB1 interactions | 4.64e-04 | 123 | 59 | 4 | int:HLA-DRB1 | |
| Interaction | SFTPC interactions | 4.79e-04 | 222 | 59 | 5 | int:SFTPC | |
| Interaction | ZDHHC15 interactions | 4.93e-04 | 125 | 59 | 4 | int:ZDHHC15 | |
| Interaction | GLI4 interactions | 4.93e-04 | 125 | 59 | 4 | int:GLI4 | |
| Interaction | CBLN4 interactions | 5.24e-04 | 127 | 59 | 4 | int:CBLN4 | |
| Interaction | ZNF169 interactions | 5.32e-04 | 54 | 59 | 3 | int:ZNF169 | |
| Interaction | ZSCAN21 interactions | 5.39e-04 | 128 | 59 | 4 | int:ZSCAN21 | |
| Interaction | PPP1R1B interactions | 5.46e-04 | 12 | 59 | 2 | int:PPP1R1B | |
| Interaction | ZNF555 interactions | 5.46e-04 | 12 | 59 | 2 | int:ZNF555 | |
| Interaction | ZNF611 interactions | 5.46e-04 | 12 | 59 | 2 | int:ZNF611 | |
| Interaction | TRGV3 interactions | 5.61e-04 | 55 | 59 | 3 | int:TRGV3 | |
| Interaction | PPP1R16A interactions | 6.23e-04 | 57 | 59 | 3 | int:PPP1R16A | |
| Interaction | RPS2 interactions | 6.25e-04 | 657 | 59 | 8 | int:RPS2 | |
| Interaction | KIF26A interactions | 6.44e-04 | 13 | 59 | 2 | int:KIF26A | |
| Interaction | KAZALD1 interactions | 6.44e-04 | 13 | 59 | 2 | int:KAZALD1 | |
| Interaction | PPP1R26 interactions | 6.44e-04 | 13 | 59 | 2 | int:PPP1R26 | |
| Interaction | ZNF235 interactions | 6.44e-04 | 13 | 59 | 2 | int:ZNF235 | |
| Interaction | LHX6 interactions | 6.56e-04 | 58 | 59 | 3 | int:LHX6 | |
| Interaction | MAST2 interactions | 6.56e-04 | 58 | 59 | 3 | int:MAST2 | |
| Interaction | INSL5 interactions | 6.56e-04 | 58 | 59 | 3 | int:INSL5 | |
| Interaction | PPP1R12C interactions | 6.56e-04 | 58 | 59 | 3 | int:PPP1R12C | |
| GeneFamily | Fibulins | 1.76e-04 | 8 | 46 | 2 | 556 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 4.85e-04 | 13 | 46 | 2 | 693 | |
| GeneFamily | Low density lipoprotein receptors | 4.85e-04 | 13 | 46 | 2 | 634 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.98e-03 | 26 | 46 | 2 | 253 | |
| GeneFamily | S ribosomal proteins | 3.37e-03 | 34 | 46 | 2 | 728 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 3.37e-03 | 34 | 46 | 2 | 487 | |
| GeneFamily | Fibronectin type III domain containing | 7.81e-03 | 160 | 46 | 3 | 555 | |
| Coexpression | NABA_MATRISOME | PCSK5 BMP6 EYS FBLN2 FBN2 MEGF8 ADAM9 MATN2 EFEMP2 BRINP2 MUC5B LTBP2 ELFN2 | 5.38e-07 | 1026 | 61 | 13 | M5889 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL | 1.65e-06 | 355 | 61 | 8 | M45758 | |
| Coexpression | NABA_MATRISOME | PCSK5 BMP6 FBLN2 FBN2 MEGF8 ADAM9 MATN2 EFEMP2 BRINP2 MUC5B LTBP2 ELFN2 | 3.00e-06 | 1008 | 61 | 12 | MM17056 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.39e-06 | 196 | 61 | 6 | M3008 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 6.57e-06 | 16 | 61 | 3 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 6.57e-06 | 16 | 61 | 3 | M2207 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 7.17e-06 | 200 | 61 | 6 | M5930 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 7.92e-06 | 117 | 61 | 5 | M39300 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 1.10e-05 | 59 | 61 | 4 | M47989 | |
| Coexpression | ENK_UV_RESPONSE_EPIDERMIS_DN | 2.38e-05 | 512 | 61 | 8 | M4508 | |
| Coexpression | KAAB_HEART_ATRIUM_VS_VENTRICLE_UP | 2.90e-05 | 256 | 61 | 6 | M10952 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_DN | 3.26e-05 | 699 | 61 | 9 | M4960 | |
| Coexpression | NABA_CORE_MATRISOME | 4.32e-05 | 275 | 61 | 6 | M5884 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 5.35e-05 | 574 | 61 | 8 | M39056 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | 7.29e-05 | 600 | 61 | 8 | M39055 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 8.33e-05 | 191 | 61 | 5 | MM17059 | |
| Coexpression | SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS | 8.81e-05 | 37 | 61 | 3 | M12802 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 8.97e-05 | 194 | 61 | 5 | M39122 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN | 9.19e-05 | 195 | 61 | 5 | M9808 | |
| Coexpression | ZHONG_PFC_MAJOR_TYPES_ASTROCYTES | 1.10e-04 | 326 | 61 | 6 | M39074 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_1_CELL | 1.23e-04 | 109 | 61 | 4 | M45707 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 1.62e-04 | 350 | 61 | 6 | M1949 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 1.68e-04 | 505 | 61 | 7 | M39167 | |
| Coexpression | MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3 | 1.81e-04 | 357 | 61 | 6 | MM828 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL1 | 2.01e-04 | 364 | 61 | 6 | M39057 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 2.17e-04 | 50 | 61 | 3 | M1259 | |
| Coexpression | SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION | 2.44e-04 | 52 | 61 | 3 | MM1118 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | 2.56e-04 | 721 | 61 | 8 | M1999 | |
| Coexpression | SENESE_HDAC2_TARGETS_DN | 2.64e-04 | 133 | 61 | 4 | M6906 | |
| Coexpression | VERRECCHIA_EARLY_RESPONSE_TO_TGFB1 | 2.73e-04 | 54 | 61 | 3 | M4737 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 2.96e-04 | 137 | 61 | 4 | M40313 | |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | 3.39e-04 | 567 | 61 | 7 | M2129 | |
| Coexpression | WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH | 3.55e-04 | 59 | 61 | 3 | M7899 | |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 3.55e-04 | 59 | 61 | 3 | M47993 | |
| Coexpression | NABA_CORE_MATRISOME | 4.15e-04 | 270 | 61 | 5 | MM17057 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.74e-07 | 177 | 62 | 6 | 7af1a19692f7fe8f691178a4e57d62bc379e3d56 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-07 | 179 | 62 | 6 | d2db9e70b780643f1e004c41a70464d0abe26088 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 2.90e-07 | 193 | 62 | 6 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.08e-07 | 195 | 62 | 6 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-B_(Artery)|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.18e-07 | 196 | 62 | 6 | f540cf17b4405a6dd38d2b6123e6541d0aac889e | |
| ToppCell | AT2_cells-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 3.27e-07 | 197 | 62 | 6 | fd7bdfa6bf5966ebc11fdd13915769429540ddbf | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.27e-07 | 197 | 62 | 6 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.27e-07 | 197 | 62 | 6 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.27e-07 | 197 | 62 | 6 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | COVID-19-Heart-Low_count_Fib|Heart / Disease (COVID-19 only), tissue and cell type | 3.37e-07 | 198 | 62 | 6 | aee3d8757642cd6bbf6dc03e78b3912c6b8e510a | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 3.58e-07 | 200 | 62 | 6 | 14ae55660f7412518dcb5cb982f6fe9f23553cfb | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-07 | 200 | 62 | 6 | c450a15e21fa72d071ed6e3b9f22de557a0f3cea | |
| ToppCell | wk_20-22-Mesenchymal-Fibroblast-intermediate_fibro|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.58e-07 | 200 | 62 | 6 | d769723f8fcb37d9b86589e0c41c1d7f16393cfe | |
| ToppCell | 18-Airway-Mesenchymal|Airway / Age, Tissue, Lineage and Cell class | 3.58e-07 | 200 | 62 | 6 | aca1e8def8ed6ae5749402d0288ad90656213de1 | |
| ToppCell | 390C-Fibroblasts|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.58e-07 | 200 | 62 | 6 | 3abe0f017fee6057ba73bd661a2bc8ec9e2bfe38 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-07 | 200 | 62 | 6 | 74ad0ae592252060ee294d7483327d765a6ba1dd | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-07 | 200 | 62 | 6 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | Tracheal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-07 | 200 | 62 | 6 | 7ba292c30d915e66ebc8026fa76492cedf64700e | |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.58e-07 | 200 | 62 | 6 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.12e-06 | 162 | 62 | 5 | 810881210e015c788814e4fe8d7a24c929cf2621 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.95e-06 | 170 | 62 | 5 | 14aa86a4f526ed6986afcb28c49225522055550c | |
| ToppCell | Club-club-3|World / Class top | 4.18e-06 | 172 | 62 | 5 | 34fbb82a2ec77dd183cf26b38edeb7e936b707bc | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 173 | 62 | 5 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-06 | 173 | 62 | 5 | 649b08a409095592cccf31883be69c754411280d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-06 | 174 | 62 | 5 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.42e-06 | 174 | 62 | 5 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.08e-06 | 179 | 62 | 5 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.08e-06 | 179 | 62 | 5 | 02c90d8306016365ed811f0c63cfb3ac7b85464c | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.08e-06 | 179 | 62 | 5 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.22e-06 | 180 | 62 | 5 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.22e-06 | 180 | 62 | 5 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.22e-06 | 180 | 62 | 5 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | COVID-19_Convalescent-Lymphoid_T/NK-CD8+_T_naive|COVID-19_Convalescent / Disease group, lineage and cell class | 5.80e-06 | 184 | 62 | 5 | 0299cd30a3ea8e861a9d529043c204048ae21d29 | |
| ToppCell | remission-CD8+_T_naive|remission / disease stage, cell group and cell class | 5.80e-06 | 184 | 62 | 5 | fe20fa4457d4a4a75689978275b0afb5f6243faf | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.96e-06 | 185 | 62 | 5 | 863a3d44c1f115942d7a2a2b63a92fe5fc768814 | |
| ToppCell | remission-CD8+_T_naive|World / disease stage, cell group and cell class | 5.96e-06 | 185 | 62 | 5 | 69304d7dd406ac7e96d51c239d7035a06d88704f | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.96e-06 | 185 | 62 | 5 | 27dbfcd40ec832d5cf757331d8af3b5176ae90fb | |
| ToppCell | COVID-19_Convalescent-CD8+_T_naive|COVID-19_Convalescent / Disease condition and Cell class | 5.96e-06 | 185 | 62 | 5 | 2f8277a0b58fb0c49fa76ff6dfa6da961da1f9f5 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-06 | 185 | 62 | 5 | 785c55d39909fac74415f24427979691e7e694e6 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.96e-06 | 185 | 62 | 5 | 1c23891e4d75f99296d1304af7a9d6c3cb28d04c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-06 | 185 | 62 | 5 | 97a1dcacbc48dc3f41c26fbb59af35c935f894d4 | |
| ToppCell | PBMC-Convalescent-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.96e-06 | 185 | 62 | 5 | ca8e921a6b45cd39474b9f86c95e7be023585c5d | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.28e-06 | 187 | 62 | 5 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.28e-06 | 187 | 62 | 5 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | droplet-Spleen-SPLEEN-1m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-06 | 188 | 62 | 5 | 713fbbd55d2853dee3df2336cada32c153cbd2a1 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.61e-06 | 189 | 62 | 5 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-06 | 190 | 62 | 5 | 55be54c39ac9eb8e2c1515d8c212130ce2b0ef88 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-06 | 190 | 62 | 5 | d0297d678498e346e56cf95fe9e3db7d3ad3b837 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.78e-06 | 190 | 62 | 5 | 24b78a6f2a763acb8f4e90a5d245c9c77605b426 | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron|World / Primary Cells by Cluster | 6.96e-06 | 191 | 62 | 5 | 4dd9c8117c4499ed9bde127baf2598603a82080d | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.96e-06 | 191 | 62 | 5 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.96e-06 | 191 | 62 | 5 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.14e-06 | 192 | 62 | 5 | f88aba74d6e8c594c32fe2bc095b5da28b4b28e9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.14e-06 | 192 | 62 | 5 | 41a8326cd5bc19ad5041068501bab4c72399222e | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.14e-06 | 192 | 62 | 5 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.32e-06 | 193 | 62 | 5 | 5bee7abc550ddaa28cbb3b9ecaf6b924ab175de0 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.50e-06 | 194 | 62 | 5 | 582db7f7fa9aa08027ae18ed607945b5d1dc908a | |
| ToppCell | COVID-19_Mild-CD8+_T_naive|COVID-19_Mild / Disease condition and Cell class | 7.50e-06 | 194 | 62 | 5 | 4e42df4f6db456ab914ddfb2a938dfc462f8b6bf | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.50e-06 | 194 | 62 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | 343B-Endothelial_cells-Endothelial-B_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.50e-06 | 194 | 62 | 5 | bda89111386398a072b70e8153b2a762298a047a | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 7.69e-06 | 195 | 62 | 5 | f86737bff21d81673238813df61a15cfe88d0b15 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.69e-06 | 195 | 62 | 5 | 4dba732c8d8ecf0ed9ece1814dc4060402199ed9 | |
| ToppCell | COVID-19-Heart-Low_count_Fib|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.69e-06 | 195 | 62 | 5 | e09590d1f51d5fa57fceb84c9f48f84b23d4d224 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.69e-06 | 195 | 62 | 5 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 7.69e-06 | 195 | 62 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 7.69e-06 | 195 | 62 | 5 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.69e-06 | 195 | 62 | 5 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.69e-06 | 195 | 62 | 5 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.69e-06 | 195 | 62 | 5 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.69e-06 | 195 | 62 | 5 | 51db90e7611f7d69980878c046505ff34212079b | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.89e-06 | 196 | 62 | 5 | e7bfd4fb400ae0c473131d0fa306c26be08a6d03 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.89e-06 | 196 | 62 | 5 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 7.89e-06 | 196 | 62 | 5 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 7.89e-06 | 196 | 62 | 5 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.89e-06 | 196 | 62 | 5 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.89e-06 | 196 | 62 | 5 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.08e-06 | 197 | 62 | 5 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.08e-06 | 197 | 62 | 5 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.08e-06 | 197 | 62 | 5 | d2a4d7e92e91bcc47a7657da2e5c8a3ad7eb08ad | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 8.28e-06 | 198 | 62 | 5 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | 15-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 8.28e-06 | 198 | 62 | 5 | 3d76393e72eed59b4dd16130ef5dd1d331ba5711 | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 8.28e-06 | 198 | 62 | 5 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 8.28e-06 | 198 | 62 | 5 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.28e-06 | 198 | 62 | 5 | a883e25cb7a78b2ecfb15cef4633bdd02dfafb12 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.28e-06 | 198 | 62 | 5 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | control-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.28e-06 | 198 | 62 | 5 | a2c70840c38e9a76543060c112e7d9332dd58a89 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.28e-06 | 198 | 62 | 5 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 8.28e-06 | 198 | 62 | 5 | 74f2c7ef702b25a5b99e56121229e678ed992524 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.28e-06 | 198 | 62 | 5 | cfe2d52b19a1b4c2c2076fa1d5a69baf21a49623 | |
| ToppCell | IPF-Stromal|IPF / Disease state, Lineage and Cell class | 8.28e-06 | 198 | 62 | 5 | ece914c32c9b123b779aa9624b92e6230763a20e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.28e-06 | 198 | 62 | 5 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.28e-06 | 198 | 62 | 5 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.49e-06 | 199 | 62 | 5 | 5a425e7d11c5911ff5855c27a7f058a7ed7abbb0 | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 8.49e-06 | 199 | 62 | 5 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.49e-06 | 199 | 62 | 5 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 8.49e-06 | 199 | 62 | 5 | 66545eb7f65e450b742628fd431956e13330a0d3 | |
| ToppCell | distal-Endothelial-Artery|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 8.49e-06 | 199 | 62 | 5 | b6e9aaac047d4b64b9d97f5e174e89a424d8b36d | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 8.49e-06 | 199 | 62 | 5 | e9009eee7f77b9c9917f8e0e723001d9e76eb553 | |
| ToppCell | Nasal_Brush-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.49e-06 | 199 | 62 | 5 | aa6f1390283617c7f9aaf91d379024832ea24a9e | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.49e-06 | 199 | 62 | 5 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| Computational | Metal / Ca ion binding. | 7.13e-07 | 133 | 42 | 7 | MODULE_324 | |
| Drug | Androgen Antagonists | 1.75e-06 | 75 | 61 | 5 | ctd:D000726 | |
| Disease | hemangioblastoma (is_marker_for) | 2.52e-05 | 4 | 61 | 2 | DOID:5241 (is_marker_for) | |
| Disease | body surface area | 5.18e-05 | 643 | 61 | 8 | EFO_0022196 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 5.37e-05 | 99 | 61 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | hemangiopericytoma (is_marker_for) | 1.50e-04 | 9 | 61 | 2 | DOID:264 (is_marker_for) | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 1.50e-04 | 9 | 61 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | cancer (implicated_via_orthology) | 2.34e-04 | 268 | 61 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of skin | 2.52e-04 | 59 | 61 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 2.52e-04 | 59 | 61 | 3 | C0037286 | |
| Disease | homostachydrine measurement | 3.23e-04 | 13 | 61 | 2 | EFO_0021164 | |
| Disease | Chromosome Breaks | 3.76e-04 | 14 | 61 | 2 | C0333704 | |
| Disease | Chromosome Breakage | 3.76e-04 | 14 | 61 | 2 | C0376628 | |
| Disease | sexual dimorphism measurement | 4.25e-04 | 1106 | 61 | 9 | EFO_0021796 | |
| Disease | amino acid measurement | 4.88e-04 | 678 | 61 | 7 | EFO_0005134 | |
| Disease | esophagus squamous cell carcinoma (is_marker_for) | 4.91e-04 | 74 | 61 | 3 | DOID:3748 (is_marker_for) | |
| Disease | smoking status measurement, chronic obstructive pulmonary disease | 8.14e-04 | 88 | 61 | 3 | EFO_0000341, EFO_0006527 | |
| Disease | diffuse plaque measurement | 9.40e-04 | 758 | 61 | 7 | EFO_0010699 | |
| Disease | vital capacity | 9.40e-04 | 1236 | 61 | 9 | EFO_0004312 | |
| Disease | remission, hepatitis C virus infection | 1.03e-03 | 23 | 61 | 2 | EFO_0003047, EFO_0009785 | |
| Disease | chronic hepatitis B virus infection | 1.13e-03 | 24 | 61 | 2 | EFO_0004239 | |
| Disease | complement C4b measurement | 1.22e-03 | 25 | 61 | 2 | EFO_0008092 | |
| Disease | systemic mastocytosis | 1.22e-03 | 25 | 61 | 2 | MONDO_0016586 | |
| Disease | diabetes mellitus (implicated_via_orthology) | 1.32e-03 | 26 | 61 | 2 | DOID:9351 (implicated_via_orthology) | |
| Disease | Oral ulcer | 1.43e-03 | 107 | 61 | 3 | HP_0000155 | |
| Disease | Mental deterioration | 1.65e-03 | 29 | 61 | 2 | HP_0001268 | |
| Disease | colorectal cancer, overall survival | 1.65e-03 | 29 | 61 | 2 | EFO_0000638, MONDO_0005575 | |
| Disease | intestinal cancer (implicated_via_orthology) | 2.00e-03 | 32 | 61 | 2 | DOID:10155 (implicated_via_orthology) | |
| Disease | response to aromatase inhibitor | 2.00e-03 | 32 | 61 | 2 | GO_0061477 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEGQAPCMAHACNSS | 881 | Q15361 | |
| PKDTDCFACMNFNDS | 241 | Q15303 | |
| CGPNSHCEMDCEVNN | 871 | Q9NY47 | |
| MDGNDEGHSFELCPS | 776 | Q9NZJ5 | |
| HDLENGLMCTCPAGF | 456 | Q9NR61 | |
| QLNGMVFCPHCGEDA | 526 | Q96KQ7 | |
| CQGPFDMDSCLSRHS | 226 | O76075 | |
| NCVDACHLNPCENMG | 1906 | Q9NYQ6 | |
| NMFCAGHPSLKQDAC | 636 | P00736 | |
| GCFCPEDQILFNAHM | 5391 | Q9HC84 | |
| SFLEEHGPAMQCFLD | 666 | Q86YV0 | |
| QNESDCTCTDAHFPM | 756 | Q01804 | |
| VDECAMANSNPCEHA | 416 | Q04721 | |
| FDDCASNPCIHGICM | 646 | Q04721 | |
| NMDRSFACQCPEGHV | 501 | O00339 | |
| NECDSDPCMNGGLCH | 811 | Q5T1H1 | |
| DDGQTYNNPCMLCHE | 1016 | Q9NQ38 | |
| PRCDMDQFQCKSGHC | 3611 | Q07954 | |
| ACDCDDNHMCLDSGA | 586 | Q86SJ6 | |
| DECAMGTHTCQPGFL | 766 | P98095 | |
| CMDGFLQDPEGNCVD | 796 | P98095 | |
| PNCESCFGSHGDQCM | 691 | Q92824 | |
| ECTPEFFLHDDMCHQ | 1341 | Q92824 | |
| FFLHDDMCHQSCPRG | 1346 | Q92824 | |
| DRGEACPACQNMLFE | 306 | Q9HBH9 | |
| FCGPNVIDHFMCDLN | 166 | A6NHA9 | |
| ALVPCGHNLFCMDCA | 611 | Q86XN8 | |
| MALCPENCNAHTGAG | 1446 | Q7Z7M0 | |
| PPGMCHSDEFQCQED | 1226 | P98164 | |
| AADEPALCLQCDMND | 56 | P47928 | |
| HTSDPNNRCDMCADN | 191 | Q9NQX0 | |
| CCHGGLSPDLQSMEQ | 171 | P62136 | |
| CSQCENSGHPSCLDM | 401 | Q8WUB8 | |
| PAHQRCDGFADCMDF | 2001 | Q5VYJ5 | |
| EECEMLEGFFSHNPC | 326 | O60609 | |
| MECPQNSHYELCADT | 2731 | Q9Y6R7 | |
| NHMCGHCQDSPFKEE | 201 | Q6ZUJ4 | |
| CNDENPCEGMSRHAT | 1646 | Q9P0X4 | |
| CDGECSFPLNAHMNA | 441 | P22004 | |
| HNLGMNHDDGRDCSC | 351 | Q13443 | |
| MGEEHCAPHGECLNS | 1181 | Q14767 | |
| CNNLPGMFHCICDDG | 1506 | P35556 | |
| ECDMGAPCEQRCFNS | 206 | O95967 | |
| MQGDCNLCFEPDALL | 81 | Q504Y0 | |
| FGCNCDHAPFDAMIM | 321 | Q9UKG9 | |
| FHPVSNSCMDCNPAE | 551 | Q49A17 | |
| SDEQHCEPLCTHFMD | 1266 | Q92673 | |
| MLCAGSENHDSCQGD | 216 | Q9BZJ3 | |
| ISCLSPEMNCDGGHS | 646 | Q9H3W5 | |
| GPTCHQDLDECLMAQ | 426 | Q99466 | |
| CNCPDADIQAMEDSL | 306 | Q9C0B6 | |
| CNAMACLGEPDHNEA | 161 | O95985 | |
| CSDCGEHFPDLFHVM | 671 | P0CJ78 | |
| GHSPGCEMCSQEAFQ | 21 | Q9HC29 | |
| DLCQGSMHSPCANDL | 146 | Q9HCQ7 | |
| HQAHCEFALMDCPQC | 151 | Q9Y4K3 | |
| QAHLCVLASNCDEPM | 46 | P25398 | |
| CQAEHPMASCQDALL | 1181 | O95359 | |
| CCHGGLSPDLQSMEQ | 171 | P36873 | |
| SMDCAEGRAANLPCN | 26 | A0A087WT03 | |
| NCINGDDCMFSHDPL | 456 | Q9UPT8 | |
| LCECSFNDPNAKEMH | 586 | Q96KR1 | |
| MEFPDLGAHCSEPSC | 1 | Q8WV99 | |
| QRMHTGHLPFDCDDC | 256 | Q9NSD4 | |
| CPSDECGAGVFMASH | 121 | P62979 | |
| SLMVCELAGNPFNCE | 176 | Q5R3F8 |